Involvement of a CD47-dependent pathway in platelet adhesion on inflamed vascular endothelium under flow
- 15 June 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 101 (12) , 4836-4843
Abstract
Resting platelet adhesion to inflammatory vascular endothelium is thought to play a causal role in secondary thrombus formation or microcirculatory disturbance after vessel occlusion. However, though adhesion receptors involved in platelet-matrix interactions have been extensively studied, the molecular mechanisms involved in platelet-endothelium interactions are incompletely characterized and have been mainly studied under static conditions. Using human platelets or platelets from wild-type and CD47–/– mice in whole blood, we demonstrated that at low shear rate, CD47 expressed on human and mouse platelets significantly contributes to platelet adhesion on tumor necrosis factor-α (TNF-α)–stimulated vascular endothelial cells. Using the CD47 agonist peptide 4N1K and blocking monoclonal antibodies (mAbs), we showed that CD47 binds the cell-binding domain (CBD) of endothelial thrombospondin-1 (TSP-1), inducing activation of the platelet αIIbβ3 integrin that in turn becomes able to link the endothelial receptors intercellular adhesion molecule 1 (ICAM-1) and αvβ3. Platelet CD36 and GPIbα are also involved because platelet incubation with blocking mAbs directed against each of these 2 receptors significantly decreased platelet arrest. Given that anti-CD47 treatment of platelets did not further decrease the adhesion of anti-CD36–treated platelets and CD36 is a TSP-1 receptor, it appears that CD36/TSP-1 interaction could trigger the CD47-dependent pathway. Overall, CD47 antagonists may be potentially useful to inhibit platelet adhesion on inflamed endothelium.Keywords
This publication has 49 references indexed in Scilit:
- Dynamic Aspects Of Platelet Adhesion Under FlowClinical and Experimental Pharmacology and Physiology, 2001
- Adhesion of Activated Platelets to Endothelial Cells: Evidence for a GPIIbIIIa-dependent Bridging Mechanism and Novel Roles for Endothelial Intercellular Adhesion Molecule 1 (ICAM-1), αvβ3 Integrin, and GPIbαJournal of Experimental Medicine, 1998
- Role of Platelet-Endothelial Cell Adhesion Molecule (PECAM) in Platelet Adhesion/Aggregation Over Injured but Not Denuded Endothelium In Vivo and Ex VivoStroke, 1996
- CD36 Is Spatially Associated with Glycoprotein IIb-IIIa (αIIbβ3) on the Surface of Resting PlateletsBiochemical and Biophysical Research Communications, 1996
- Recombinant GST/CD36 Fusion Proteins Define a Thrombospondin Binding DomainJournal of Biological Chemistry, 1995
- The Role of PECAM‐1 in Vascular Cell BiologyaAnnals of the New York Academy of Sciences, 1994
- Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins.Journal of Clinical Investigation, 1993
- Thrombospondin sequence motif (CSVTCG) is responsible for CD36 bindingBiochemical and Biophysical Research Communications, 1992
- Integrin-associated protein: a 50-kD plasma membrane antigen physically and functionally associated with integrins.Journal of Cell Biology, 1990
- The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirusCell, 1990